Ni Chen

5.2k total citations · 1 hit paper
165 papers, 4.0k citations indexed

About

Ni Chen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ni Chen has authored 165 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Molecular Biology, 39 papers in Cancer Research and 23 papers in Oncology. Recurrent topics in Ni Chen's work include MicroRNA in disease regulation (17 papers), Angiogenesis and VEGF in Cancer (17 papers) and Cancer-related molecular mechanisms research (12 papers). Ni Chen is often cited by papers focused on MicroRNA in disease regulation (17 papers), Angiogenesis and VEGF in Cancer (17 papers) and Cancer-related molecular mechanisms research (12 papers). Ni Chen collaborates with scholars based in China, United States and Germany. Ni Chen's co-authors include Jun Zhang, Zhi‐Hui Zhan, Yun Li, Yuhui Shi, Ying Lin, Henry Shu-Hung Chung, Wei–Neng Chen, Jianbo Wu, Xueqin Chen and Qiao Zhou and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Ni Chen

153 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Particle Swarm Optimization With an Aging Leader and Challengers

2012 504 citations Ni Chen et al. profile →

Peers

Countries citing papers authored by Ni Chen

Since Specialization

Citations

This map shows the geographic impact of Ni Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ni Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ni Chen more than expected).

Fields of papers citing papers by Ni Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ni Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ni Chen. The network helps show where Ni Chen may publish in the future.

Co-authorship network of co-authors of Ni Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Ni Chen. A scholar is included among the top collaborators of Ni Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ni Chen. Ni Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Spleen‐Targeted Tolerogenic mRNA‐LNPs Vaccine for the Treatment of Experimental Asthma 2025 ·Advanced Science ·Fazhan Wang, (unknown), Xiaohan Lou, Fang Wu, (unknown), Xiaohan Yao, Jiajia Wan, Xixi Duan, W. Deng, (unknown), Lijing Zhang, Guangjie He, Ming Wang, Ni Chen, Ningjing Lei, Zhihai Qin	9
2	A review of the traditional uses, chemical compounds, pharmacological effects and modern clinical applications of Dahuang Huanglian Xiexin Decoction 2025 ·Fitoterapia ·Ni Chen, Rui Tian, Xiao Yang, Chongbo Zhao, Yuwei Wang, Peng Zhao, Zhang Li, Kan Wang, Grace Zhang, Yuping Tang	1
3	Hypericum Perforatum-Derived Exosomes-Like Nanovesicles: A Novel Natural Photosensitizer for Effective Tumor Photodynamic Therapy 2025 ·International Journal of Nanomedicine ·(unknown), Ni Chen, (unknown), Yuqian He, Tao Zhang, Lu Yu, (unknown), Jin Xu, (unknown), Youkun Zheng, Liqun Wang, Mao Luo, Jianbo Wu	13
4	Time-programmed release of curcumin and Zn2+ from multi-layered RSF coating modified PET graft for improvement of graft-host integration 2024 ·International Journal of Biological Macromolecules ·(unknown), Ni Chen, Luyi Sun, Dandan Sheng, Yuting Zhong, (unknown), Chengxuan Yu, Xing Yang, Yuefeng Hao, Shiyi Chen, Zhengzhong Shao, Jun Chen	5
5	Facile Preparation of a Photo-Cross-Linked Silk Fibroin-Poly Ionic Liquid Hydrogel with Antifreezing and Ion Conductive Properties 2024 ·ACS Applied Materials & Interfaces ·(unknown), Xuyang Chen, Wen‐Juan Shi, Ni Chen, Yi Liu, Bo Zhang, Zhengzhong Shao	12
6	The Effective Treatment of Purpurin on Inflammation and Adjuvant-Induced Arthritis 2023 ·Molecules ·(unknown), Caihong Shen, (unknown), Ni Chen, Ying Lin, Yuan Fang, Huiling Yang, (unknown), (unknown), Ruoting Zhan, (unknown)	11
7	Combined conventional ultrasonography with clinicopathological features to predict axillary status after neoadjuvant therapy for breast cancer: A case–control study 2023 ·British Journal of Radiology ·(unknown), (unknown), (unknown), Di Ou, (unknown), Chen Chen, (unknown), Ni Chen, (unknown), Yifan Wang, Dong Xu	0
8	IFNγ blockade in capillary leak site improves tumour chemotherapy by inhibiting lactate-induced endocytosis of vascular endothelial-cadherins 2023 ·International Journal of Biological Sciences ·Ruirui Wang, Ni Chen, Xiaohan Lou, Lijing Zhang, Linlin Wang, Xiaohan Yao, Xixi Duan, Jiajia Wan, Pan Li, Zhihai Qin	4
9	Spleen-selective co-delivery of mRNA and TLR4 agonist-loaded LNPs for synergistic immunostimulation and Th1 immune responses 2023 ·Journal of Controlled Release ·(unknown), Lijing Zhang, (unknown), (unknown), (unknown), Xiaohan Lou, Yangyang Liu, Xiaohan Yao, Yuqiao Sheng, Yan Yan, Ni Chen, Ming Wang, (unknown), (unknown), Zhihai Qin	53
10	Ultrasound and clinicopathological characteristics-based model for prediction of pathologic response to neoadjuvant chemotherapy in HER2-positive breast cancer: a case–control study 2023 ·Breast Cancer Research and Treatment ·(unknown), (unknown), (unknown), Di Ou, Chen Chen, (unknown), Ni Chen, (unknown), Liping Wang, Chen Yang, Wei Li, Jincao Yao, Dong Xu	6
11	Photomodulation alleviates cellular senescence of aging adipose-derived stem cells 2023 ·Cell Communication and Signaling ·Tao Zhang, (unknown), Xin Shu, (unknown), (unknown), (unknown), (unknown), Ni Chen, (unknown), (unknown), Tian Li, Jianbo Wu	8
12	Glycation of Tie-2 Inhibits Angiopoietin-1 Signaling Activation and Angiopoietin-1-Induced Angiogenesis 2022 ·International Journal of Molecular Sciences ·Haiyan Zhou, (unknown), Yongjie Li, (unknown), Xin Deng, Ni Chen, Tian Li, Youkun Zheng, Rong Li, Mao Luo, Jianbo Wu, Liqun Wang	11
13	Claudin-12 Deficiency Inhibits Tumor Growth by Impairing Transendothelial Migration of Myeloid-Derived Suppressor Cells 2022 ·Cancer Research ·Hong Cao, Ni Chen, (unknown), Ruoqi Wang, Rosel Blasig, Reiner F. Haseloff, Yue Qin, Jie Lan, Xiaohan Lou, Pan Ma, Xiaohan Yao, Linlin Wang, Fei Wang, Linyu Zhu, Ningjing Lei, Ingolf E. Blasig, Zhihai Qin	7
14	Circulating microRNAs as emerging regulators of COVID-19 2022 ·Theranostics ·Yulong Liang, Dan Fang, Xiaojun Gao, (unknown), Ni Chen, Jianbo Wu, Min Zeng, Mao Luo	25
15	Statin-Induced Geranylgeranyl Pyrophosphate Depletion Promotes Ferroptosis-Related Senescence in Adipose Tissue 2022 ·Nutrients ·Xin Shu, Jiaqi Wu, (unknown), Tao Zhang, (unknown), (unknown), Jin Xu, (unknown), Liqun Wang, Ni Chen, Mao Luo, (unknown), (unknown)	14
16	Plant grafting relieves asymmetry of jasmonic acid response induced by wounding between scion and rootstock in tomato hypocotyl 2020 ·PLoS ONE ·Jiaqi Wang, Dongliang Li, Ni Chen, Jingjing Chen, Changjun Mu, Kuide Yin, Yuke He, (unknown)	8
17	Angiopep2-Conjugated Star-Shaped Polyprodrug Amphiphiles for Simultaneous Glioma-Targeting Therapy and MR Imaging 2020 ·ACS Applied Materials & Interfaces ·(unknown), Guhuan Liu, Ni Chen, Jing Wu, (unknown), Yinfeng Qian, Lei Zhang, Dandan Zhou, Y Yu	34
18	Bevacizumab in Combination with Modified FOLFOX6 in Heavily Pretreated Patients with HER2/Neu-Negative Metastatic Breast Cancer: A Phase II Clinical Trial 2015 ·PLoS ONE ·Ting Li, Biyun Wang, Zhonghua Wang, Joseph Ragaz, Jian Zhang, Si Sun, Jun Cao, Fangfang Lv, Leiping Wang, Sheng Zhang, Ni Chen, Zhenhua Wu, Jie Xie, Xichun Hu	6
19	IFN-γ–Mediated Downregulation of LXA4 Is Necessary for the Maintenance of Nonresolving Inflammation and Papilloma Persistence 2013 ·Cancer Research ·Chunhui Wang, (unknown), Xiaoman Liu, Ni Chen, Jianhong Liu, Ulrike Erben, Zhihai Qin	20
20	Quality Standards of Lianzhi Xiaoyan Tablets 2011 ·Zhongguo yaofang ·Ni Chen	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact